That's a very interesting question. Actually, about 15% of our revenues go back into research and development. That meets the definitions of the tax act.
The brand name companies in Canada have been declining. They spend about 8%. Surprisingly, we spend twice as much in Canada on research as the brand name companies do as a proportion of sales. The reason is that generic drugs in Canada are actually made here. They're researched here, they're developed here, they're formulated here, they're manufactured here, and they're sold here. That's why the research is so high in Canada.